Cinzia Radesich

Dr. Cinzia Radesich

University of Trieste, Trieste, Friuli-Venezia Giulia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
CRCinzia Radesich
Cinzia Radesich
EMEva Del Mestre
Eva Del Mestre
KMKristen Medo
Kristen Medo
GVGiancarlo Vitrella
Giancarlo Vitrella
PMPaolo Manca
Paolo Manca
GSGianfranco Sinagra
Gianfranco Sinagra
Cardiac involvement is a rare but relevant manifestation of Lyme disease that frequently presents as atrioventricular block (AVB). Immune-mediated injury has been implicated in the pathogenesis of Lyme carditis due to possible cross-reaction between Borrelia burgdorferi antigens and cardiac epitopes. The degree of the AVB can fluctuate rapidly, with two-thirds of patients progressing to complete AVB. Thus, continuous heart rhythm monitoring is essential, and a temporary pacemaker may be necessary. Routinely permanent pacemaker implantation, however, is contraindicated because of the frequent transient nature of the condition. Antibiotic therapy should be initiated as soon as the clinical suspicion of Lyme carditis arises to reduce the duration of the disease and minimize the risk of complications. Diagnosis is challenging and is based on geographical epidemiology, clinical history, signs and symptoms, serological testing, ECG and echocardiographic findings, and exclusion of other pathologies. This paper aims to explain the pathophysiological basis of Lyme carditis, describe its clinical features, and delineate the treatment principles.

18 July 2025 in European Heart Journal
Verified
Journal Article
Closed access
Giovanni PerettoGiovanni Peretto
Giovanni Peretto
MMMarco Merlo
Marco Merlo
AAAlessandro Ambrosi
Alessandro Ambrosi
EBElena Bacigalupi
Elena Bacigalupi
Andrea VillatoreAndrea Villatore
Andrea Villatore
GSGianfranco Sinagra
Gianfranco Sinagra
Background and Aims: The prediction of the first major arrhythmic event (MAE) is still an unmet need in the recently defined scenario of non-dilated left ventricular cardiomyopathy (NDLVC). Methods: A cohort of 337 patients with NDLVC and no history of MAE was retrospectively identified at two large centres. Patient-tailored diagnostic workup included cardiac magnetic resonance (CMR), endomyocardial biopsy, and genetic testing. The primary endpoint was the occurrence of the first MAE, including sustained ventricular tachycardia (VT), ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy, by 60-month follow-up. A pool of 216 NDLVC patients from 11 European centres served as a validation cohort. Results: In the study cohort (mean age 37 ± 15 years, 62% male), the mean left ventricular ejection fraction (LVEF) was 52 ± 8%, and 79% of patients had late gadolinium enhancement (LGE) at baseline CMR. By 60-month follow-up, 51 patients (15%) experienced a MAE. The primary endpoint was predicted by male sex [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.3–4.4, P = .007], baseline non-sustained VT (HR 3.1, 95% CI 1.7–5.6, P < .001), LVEF < 45% (HR 5.5, 95% CI 2.7–11.0, P < .001), septal (HR 2.0, 95% CI 1.0–4.0, P = .046) and ring-like pattern of LGE (HR 1.3, 95% CI .6–2.6, P = .54), pathogenic/likely pathogenic variants in guideline-defined high-risk genes (HR 4.6, 95% CI 2.3–9.1, P < .001), and biopsy/CMR-proven myocardial inflammation (HR 15.7, 95% CI 6.1–40.3, P < .001). The results were confirmed in the validation cohort (Uno’s C-index 0.81, 95% CI .75–.88). A novel risk score was subsequently derived. Conclusions: In NDLVC, male sex, non-sustained VT, LVEF < 45%, septal and ring-like LGE, high-risk genotypes, and myocardial inflammation predicted the first episode of MAE by 60 months.

21 April 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
Giovanni PerettoGiovanni Peretto
Giovanni Peretto
NPNicolas Piriou
Nicolas Piriou
AGAlessio Gasperetti
Alessio Gasperetti
BBBarbara Bauce
Barbara Bauce
Andrea VillatoreAndrea Villatore
Andrea Villatore
MMMarco Merlo
Marco Merlo
Background: Desmosomal “hot‐phase” cardiomyopathy (HPC), characterized by bursts of myocardial inflammation mimicking acute myocarditis (AM), carries relevant risks of adverse outcomes. This study aimed to identify diagnostic “red flags” favoring HPC over AM. Methods: Patients (n=134) receiving a first diagnosis of AM, proven by endomyocardial biopsy or cardiac magnetic resonance plus troponin elevation, were retrospectively identified at a referral center. HPC was defined by presence of pathogenic desmosomal gene variants (DGVs). Clinical, imaging, and electrical features were compared between HPC cases and controls with gene‐negative AM to identify red flags. Diagnostic algorithms were derived and tested in an external multicenter cohort of DGV carriers (n=30). Results: Patients with HPC (n=22; 91% DSP +) were more frequently female (73% versus 24%, P <0.001) and younger than unmatched controls with AM (32±14 versus 41±14 years, P =0.007). When matched 1:1 by age, sex, and presentation, DGV carriers showed distinctive red flags: family history of cardiomyopathy/AM/sudden death; recurrent troponin peaks; persistent left ventricular systolic dysfunction; right ventricular involvement; ring‐like late gadolinium enhancement; late gadolinium enhancement persistence or extension; low QRS voltages; life‐threatening ventricular arrhythmias at 1000/24 hours ventricular ectopy; and recurrent nonsustained ventricular tachycardia. A “first‐contact” algorithm based on female sex and age <30 years achieved 77% accuracy, identifying 63% of DGV carriers in the external cohort. An alternative algorithm incorporating ring‐like late gadolinium enhancement, right ventricular involvement, and family history showed higher accuracy (93%) and yield (93%). Conclusions: Myocarditis in DGV carriers predominantly affects young women. A red flag‐based approach improves recognition of desmosomal HPC over classic AM.

1 October 2026 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Open access
MPMaria Perotto
Maria Perotto
CRCinzia Radesich
Cinzia Radesich
APalessia paldino
alessia paldino
Ilaria GandinIlaria Gandin
Ilaria Gandin
JVJob Verdonschot
Job Verdonschot
MFMatteo Dal Ferro
Matteo Dal Ferro
BACKGROUND: Titin truncating variants ( TTN tv) represent the most common genotype underlying dilated cardiomyopathy but are also detected in the general population, exhibiting incomplete penetrance and marked phenotypic variability. This heterogeneity complicates clinical interpretation and risk stratification. Emerging molecular evidence suggests that truncating location within the gene may influence disease mechanisms. We aimed to investigate whether TTNt v location also affects clinical phenotype and prognosis. METHODS: We established an international multicenter registry of phenotypically affected carriers of pathogenic or likely pathogenic TTN tv. Patients were classified into 3 groups: A-band, Z/I-band, and M-band. A case-control study assessed the enrichment of TTN tv across regions. The primary outcome was a composite of all-cause mortality and heart transplantation. Secondary outcomes included: (1) sudden cardiac death or major ventricular arrhythmias and (2) heart failure-related death/heart transplantation/left ventricular assist device implantation. RESULTS: The study included 467 patients (81% probands, 73% men, median age 47 years, 81% dilated cardiomyopathy phenotype). Most carried TTN tv in the A-band (80% versus 15% Z/I-band and 5% M-band). All groups showed enrichment compared with GnomAD, with greater Bayesian-estimated penetrance for A-band variants. Over a median follow-up of 83 months, the primary end point was similar across groups. However, the risk of sudden cardiac death/major ventricular arrhythmias was significantly higher in M-band carriers (45% M-band versus 23% Z/I-band versus 12% A-band; P =0.001), especially as the first disease manifestation. Band location independently predicted sudden cardiac death/major ventricular arrhythmias risk, whereas left ventricular ejection fraction was predictive only in A- and Z/I-band groups. CONCLUSIONS: TTN tv are differently enriched across the gene in patients with dilated cardiomyopathy/non-dilated left ventricular cardiomyopathy. Penetrance and risk of sudden cardiac death/major ventricular arrhythmias differ according to variant location, supporting the TTN truncation site as a parameter that should be considered for personalized risk stratification in TTN cardiomyopathy.